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The effects of diabetes share care program in southern TaiwanType 2 diabetes is a growing global pandemic and its
alarming increase in prevalence raises significant concerns.
The age-standardized prevalence of Type 2 diabetes was 6.5%
for men and 6.6% for women and is afflicted 1,524,851 people
by the end of 2005 in Taiwan.1 Diabetes and its complications
are known to place a tremendous burden on society and on the
cost of health care. A number of single risk factor intervention
trials targeting hyperglycemic, dyslipidemia, and hypertension
have shown major beneficial effects on long-term outcomes.
The Steno-2 study showed that intensive multifactorial inter-
vention for an average 7.8 years cut cardiovascular events,
nephropathy, and retinopathy by about 50% when compared
with conventional treatment.2 A subsequent analysis of those
factors that could be responsible for the dramatic reduction in
cardiovascular events in the Steno-2 study by the United
Kingdom Prospective Diabetes Study risk engine showed that
reduction in total cholesterol had the major impact of the
overall benefit followed by blood pressure lowering and gly-
cemic control.3 American Diabetes Association (ADA) also
suggested that diabetic people needs multifactorial treatment
and recommended that glycemic, blood pressure, and choles-
terol targets must be A1C less than 7.0%, blood pressure less
than 130/80 mmHg, and low-density lipoprotein (LDL)
cholesterol less than 100 mg/dL, respectively.4
Health education is an essential element of diabetes care and
ADA recommended that people with diabetes should receive
diabetes self-management education according to the national
standard.4 Taiwan Diabetes Shared Care Program (DSCP) was
initiated by Bureau of Health Promotion and supported by
Bureau of National Health Insurance, which is a national stan-
dard in Taiwan since 2003. In this issue of the Journal of the
Chinese Medical Association, Dr Hao et al. evaluate the meta-
bolic outcomes of DSCP for Type 2 diabetic patients in southern
Taiwan.5 All participants recruited in DSCP were introduced to
self-care, nutrition, and other health issues by certified diabetes
nurses and dietitians at the beginning of the program. Patients
were routinely monitored by taking fasting blood glucose, A1C,
lipid profiles, serum creatinine, urine protein, and eye fundi
examinations. Based on these measurements, physicians,
nurses, and dietitians would reinforce the aims of the education
program for every 3 months. However, this is a study without
controls and the sample size is too small to conclude the
promotion of the system to every patient with Type 2 diabetes.
Their data revealed that the percentage of patients recruited in1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.05.001the DSCP program achieving glycemic target increased from
25.8% to 32.3%, blood pressure target increased from 41.9% to
58.1%, and LDL cholesterol target increased from 31.5% to
58.1% after 3-year intervention. They also found that the
proportion of patients reached all the three treatment goals
increased from 4.03% at baseline to 4.84% and 8.87% after 1-
year and 3-year DSCPs, respectively. Their data revealed that
the improvement in control of hyperglycemia, blood pressure,
and hypercholesterolemia after completion of 1- and 3-year
interventions is low. They concluded that DSCP is suggestive
to patients with low diabetes duration; high baseline A1C, blood
pressure, and LDL cholesterol; and low baseline high-density
lipoprotein cholesterol.
It is clear that optimal diabetes management requires an
organized, systematic approach and involvement of a coordi-
nated team of dedicated health care professionals working in
an environment where patient-centered high-quality care is the
priority.4 Diabetes self-management education is the ongoing
process of facilitating the knowledge, skill, and ability
necessary for diabetes self-care, which is a critical element of
care for all patients with diabetes and is necessary to improve
patient outcomes.6 Non-compliance with instructions for
taking medications and non-adherence to suggestions about
lifestyle changes have been shown to counter any positive
pharmacologic effects. These problems can be addressed by
a comprehensive diabetic education program. Diabetes
education is effective for improving clinical outcomes and
quality of life, but it is difficult to define the quality of diabetes
education and to provide evidence-based education. The
American Association of Diabetes Educators Outcome Stan-
dards for Diabetes Education specify self-management
behavior as the key outcome, in which knowledge can be
translated into self-management behavior.7 Effective diabetes
education is one contributor to longer-term, higher-order
outcomes such as clinical status (e.g. Control of glycemia,
blood pressure, and cholesterol), health status (e.g. Avoidance
of diabetes complications), and subjective quality of life.7
Many studies have found that diabetes self-management
education is associated with improved diabetes knowledge
and improved self-care behavior, lower A1C, lower body
weight, improved quality of life, and lower costs.4 This has
been accompanied by improvements in lipid and blood pres-
sure control and led to substantial reduction in end-stage
microvascular complications in those with diabetes.4 Somehinese Medical Association. All rights reserved.
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however, more unpublished data might reveal more disap-
pointing results. Thank to Dr. Hao and his colleagues who
frankly presented their results of DSCP and also discussed the
weak point of this program in their hospitals.5 They concluded
that the improvement in control of hyperglycemia, blood
pressure, and hypercholesterolemia after completion of 1- and
3-year interventions is low.
There has been steady improvement in the proportion of
diabetic patients achieving recommended levels of A1C, blood
pressure, and cholesterol in the last 10 years. Mean A1C has
declined from 7.82% in 1999e2000 to 7.18% in 2003e2004
based on National Health and Nutrition Examination Survey
data in United States.8 They concluded that this trend may
represent an important improvement in diabetes care and is
encouraging for future education of diabetes-related compli-
cations. However, mean A1C has no significant difference
from 8.1% in 1999 to 7.9% in 2006 based on national surveys
in Taiwan.9,10 The percentage of subjects who met the ADA
recommended goals was 57.1% that achieved A1C level less
than 7.0%, 45.5% had blood pressure less than 130/80 mmHg,
and 46.5% had LDL cholesterol less than 100 mg/dL, with
12.2% of people achieving all the three treatment goals in
2003e2006 NHANES.11 Yu et al. undertook nationwide
surveys to evaluate the status of diabetes control in 7,541
diabetic subjects among 114 accredited Diabetes Health
Promotion Center in Taiwan in 2006.10 There were 32.4% of
Type 2 diabetic patients who achieved an A1C of <7.0%,
30.9% had a blood pressure <130/80 mmHg, and 35.3% had
a LDL cholesterol <100 mg/dL, whereas only 4.1% of
patients with diabetes achieving all three treatment goal in
2006 from Taiwan nationwide survey.10
From the NHANES data, there was a significant improve-
ment in the proportion of people with diabetes achieving the
ADA recommended targets,11 but the Taiwan nationwide
survey revealed that only a small fraction of diabetic subjects
have reached the guideline goals.10 Although the proportion of
patients achieving these therapeutic goals was also low in this
small study from local hospital, the target rate was signifi-
cantly increased from 4.03% to 8.87% after 3-year interven-
tion.5 In my view, if we could pay more attention to
characteristics that help in attainment of glycemic, blood
pressure, and cholesterol control, we may improve diabetes
outcomes and diminish the future health care burden from
various diabetes complications.Harn-Shen Chen*
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